Northwest Biotherapeutics (NWBO) EBIT Margin Growth (5y) (2015 - 2026)
Northwest Biotherapeutics (NWBO) EBIT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Northwest Biotherapeutics | 253,653.43 | -1.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 598,181.00 |
| Dec 31, 2025 | 263,441.00 |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 36.55 Mn |
| Mar 31, 2025 | -324,206.00 |
| Dec 31, 2024 | -725,772.00 |
| Sep 30, 2024 | -303,548.00 |
| Jun 30, 2024 | -228,197.00 |
| Mar 31, 2024 | -325,281.00 |
| Dec 31, 2023 | -406,611.00 |
| Sep 30, 2023 | -134,800.00 |
| Jun 30, 2023 | 56,686.00 |
| Mar 31, 2023 | 520,561.00 |
| Dec 31, 2022 | 5.31 Mn |
| Sep 30, 2022 | 196,777.00 |
| Jun 30, 2022 | 769,605.00 |
| Mar 31, 2022 | 1.45 Mn |
| Sep 30, 2021 | 1.32 Mn |
| Jun 30, 2021 | 658,634.00 |
| Mar 31, 2021 | -78,193.00 |